Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Dis Esophagus ; 26(5): 528-37, 2013 Jul.
Article in English | MEDLINE | ID: mdl-22816673

ABSTRACT

The purpose of this study was to clarify the role of breast cancer anti-estrogen resistance 1 (BCAR1) expression in relation to vascular endothelial growth factor (VEGF), p53, and proliferation in esophageal squamous cell cancer (ESCC). Expression of BCAR1, VEGF, p53, and the ki-67 proliferative index were examined by tissue microarray and immunohistochemistry in 106 specimens with ESCC and matched adjacent normal tissues. Among them, 40 cases were simultaneously examined by Western blot. Both Western blot and immunohistochemistry showed that BCAR1 expression was substantially higher in ESCC than in adjacent normal tissues (P < 0.001). BCAR1 expression was significantly connected with degree of tumor differentiation, with poorly differentiated tumors showing higher BCAR1 expression (P < 0.001). BCAR1 expression was significantly and positively correlated with VEGF and p53 expression levels (r= 0.541, P < 0.001; r= 0.374; P < 0.001) but not proliferative index (r= 0.44; P= 0.066). Additionally, a significant relationship was also observed between VEGF and p53 (r= 0.321; P= 0.001). Kaplan-Meier survival analysis revealed that patients with high BCAR1 expression had significantly shorter survival times than those with low BCAR1 expression levels (median survival 40 months vs. 27 months, P= 0.09). Multivariate analysis also revealed that levels of BCAR1 expression (hazard ratio 2.250, P= 0.015) was a significant and independent prognostic indicator. High expression of BCAR1 is associated with elevated VEGF and p53 expression levels, as well as poor prognosis in ESCC. Therefore, BCAR1 may be a potential candidate for predicting prognosis and a new therapy target for ESCC.


Subject(s)
Carcinoma, Squamous Cell/chemistry , Crk-Associated Substrate Protein/analysis , Esophageal Neoplasms/chemistry , Carcinoma, Squamous Cell/pathology , Esophageal Neoplasms/pathology , Esophagus/chemistry , Female , Humans , Immunochemistry , Kaplan-Meier Estimate , Ki-67 Antigen/analysis , Male , Middle Aged , Mitotic Index , Prognosis , Survival Rate , Tissue Array Analysis , Tumor Suppressor Protein p53/analysis , Vascular Endothelial Growth Factor A/analysis
2.
Dis Esophagus ; 24(6): 404-10, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21309912

ABSTRACT

Commonly used procedures for reconstructing hypopharyngeal and cervical esophageal defects resulting from total laryngopharyngectomy (TL) are the gastric conduit or colon transposition as well as microvascularized free flaps. Herein we designed an alternative procedure utilizing bilateral platysma myocutaneous flaps (PMCFs) for the reconstruction of hypopharyngeal and cervical esophageal defects. This report summarizes the technical description of this procedure. TL and cervical esophagectomy were performed and bilateral PMCFs were harvested for reconstruction of hypopharyngeal and cervical esophageal defects in 25 patients aged between 46 and 73 years (mean 58.7 ± 16.2 years). All these patients had advanced-stage (IV) cancer with involvement of the cervical esophagus. Operative time ranged from 176 to 382 minutes (average 243 ± 91 minutes) and the mean intraoperative blood loss was 294 ± 119mL. There were six cases of anastomotic leak (24.0%) and two of them (8.0%) developed anastomotic stricture. Neither flap necrosis nor postoperative death was observed. The majority of our patients (68.0%) were restored to a normal unrestricted oral diet after surgery. The 3-year and 5-year actuarial survival rates were approximately 54.7% and 26.1%, respectively. We conclude that reconstruction of the cervical esophagus with bilateral PMCFs is a valuable method for treating advanced hypopharyngeal carcinoma.


Subject(s)
Carcinoma, Squamous Cell/surgery , Esophagoplasty/methods , Hypopharyngeal Neoplasms/surgery , Neck Muscles/transplantation , Skin Transplantation , Surgical Flaps , Aged , Anastomotic Leak/etiology , Esophagoplasty/adverse effects , Female , Humans , Kaplan-Meier Estimate , Laryngectomy , Male , Middle Aged , Pharyngectomy , Retrospective Studies , Time Factors
3.
Dis Esophagus ; 22(5): 434-8, 2009.
Article in English | MEDLINE | ID: mdl-19191858

ABSTRACT

In this article, we reviewed our experience of treatment of the delayed intrathoracic nonmalignant esophageal perforation employing modified intraluminal esophageal stent. Between February 1990 and August 2006, eight patients were included in this study. Five patients experienced sepsis. The interval time between perforation and stent placement ranged from 36 h to 27 days (average, 8.6 days). Esophageal stenting and throracotomy for foreign body removal were performed in four patients. The remaining four patients underwent stent placement and thoracostomy. Nutrition was initiated through gastrostomy after 7 to 10 days after the stenting. The stent was removed after the patients resumed oral intake of food and the esophagogram showed that perforation was closed. There was no death in this group. Signs of sepsis remitted 1 week after stent placement. Complications included stress ulcer, stimulative cough, and pneumonia each. Stent removal ranged 32 to 120 days (average 66.7) after its placement. The stent was kept in place for 4 months to prevent formation of esophageal stricture in one patient with caustic esophageal burns. The follow-up was completed in all the patients. The mean follow-up period was 59 months (range 12-180). One patient with caustic esophageal burn underwent cicatricial esophagectomy and gastric transposition 3 years later due to the esophageal stricture. Barium swallow demonstrated that there was a diverticulum-like outpouching in one patient and slight esophageal stricture at T2 and T3 level in another. One patient developed reflux esophagitis 5 years after stent removal. All the patients finally had a normal intake of food. Modified esophageal stenting is an effective method to manage the delayed intrathoracic esophageal perforation. Prevention of stent migration and its convenient adjustment might be the major advantages of this method.


Subject(s)
Esophageal Perforation/surgery , Stents , Adult , Burns, Chemical/complications , Burns, Chemical/surgery , Caustics/adverse effects , Cough/etiology , Diverticulum/etiology , Enteral Nutrition , Esophageal Diseases/etiology , Esophageal Perforation/etiology , Esophageal Stenosis/surgery , Esophagitis, Peptic/etiology , Esophagus/injuries , Esophagus/surgery , Female , Follow-Up Studies , Foreign Bodies/complications , Foreign Bodies/surgery , Gastrostomy , Humans , Male , Middle Aged , Pneumonia/etiology , Postoperative Complications , Sepsis/etiology , Stress, Physiological , Thoracostomy , Thoracotomy/methods , Time Factors , Ulcer/etiology
4.
Dis Esophagus ; 21(8): 730-6, 2008.
Article in English | MEDLINE | ID: mdl-18564169

ABSTRACT

The downregulation of zinc ribbon domain-containing 1 (ZNRD1) protein was recently found to partially reverse the resistance of human leukemia cells toward chemical therapeutic drugs. Therefore, the ZNRD1 protein might be involved in the process of DNA damage and repair. To explore the possible protective effects of ZNRD1 on DNA damage induced by ultraviolet (UV)-C irradiation in human esophageal squamous cancer cell line EC109, we designed and transfected a expression vector into EC109 cells, and established an overexpression cell line. The single-cell gel electrophoresis (comet assay) was used to investigate the DNA damage and repair in UV-C-irradiated control and transfected cells. It was found that the ZNRD1-expressing cells exhibited a significant enhanced DNA repair capacity. Moreover, the overexpression of ZNRD1 could upregulate the expression of excision repair cross-complementing 1 (ERCC1) gene. Collectively, these findings suggested that ZNRD1 might play an important role in the process of DNA damage and repair by regulating the expression of ERCC1.


Subject(s)
Carcinoma, Squamous Cell/metabolism , DNA Damage/radiation effects , DNA Repair/radiation effects , DNA-Binding Proteins/metabolism , Endonucleases/metabolism , Esophageal Neoplasms/metabolism , Carcinoma, Squamous Cell/etiology , Carcinoma, Squamous Cell/pathology , Cell Culture Techniques , Cell Line, Tumor/radiation effects , Comet Assay , DNA Damage/physiology , DNA Repair/physiology , DNA-Binding Proteins/genetics , Endonucleases/genetics , Esophageal Neoplasms/etiology , Esophageal Neoplasms/pathology , Humans , RNA, Messenger/metabolism , Ultraviolet Rays/adverse effects
5.
Dis Esophagus ; 21(1): 57-62, 2008.
Article in English | MEDLINE | ID: mdl-18197940

ABSTRACT

We present our experience in the management of complications after a colon interposition for corrosive esophageal burns. From April 1976 to December 2006, 85 patients with caustic esophageal burns were included in this study. The superior belly median incision with an anterior border incision of the left sternocleidomastoid was used. Anastomosis between the colon and the cervical esophagus was performed in 68 and between the colon and pharyngeal portion in 14 patients. An esophageal scar part resection and gastric-esophageal anastomosis was performed in one patient who had been given an unsuccessful colon and jejunum interposition at another institute. An anastomotic modeling operation was performed in one patient with anastomotic stricture who had been managed with colon interposition at another institute. Exploratory thoracotomy and gastrostomy was performed in one patient who had an unsuccessful colon interposition at another institute. Seven of 14 patients (8.5% of 17.1%) died with serious complications such as aspirated pneumonia, interposition colon necrosis, abdominal wound dehiscence and degradation of swallowing and concordance function. However, others with such serious complications survived and were discharged for rehabilitation after corresponding treatment. The 25 patients (30.1%) with other mild complications were discharged for rehabilitation and corresponding management. Two patients from other institutes were discharged for rehabilitation and one was lost to follow-up. The most dangerous complication of this procedure is colon necrosis, and the stomach is the best organ for re-operation. Otherwise, aspiration in infants due to hypoplasia and degradation of swallowing co-ordination needs attention. Peri-operative management is very important, including the control of mediastinal and pulmonary infection and systemic nutritional support to avoid abdominal wound dehiscence. The platysma flap is an excellent method for the treatment of anastomotic stricture.


Subject(s)
Burns, Chemical/surgery , Colon/transplantation , Esophagus/injuries , Postoperative Complications/therapy , Adolescent , Adult , Aged , Anastomosis, Surgical , Child , Child, Preschool , Colon/pathology , Esophagus/surgery , Female , Gastrostomy , Humans , Jejunum/transplantation , Male , Middle Aged , Necrosis , Pharynx/surgery , Pneumonia, Aspiration/etiology , Reoperation , Stomach/surgery
6.
Dis Esophagus ; 19(5): 389-93, 2006.
Article in English | MEDLINE | ID: mdl-16984538

ABSTRACT

In this article we present our experience in the management of achalasia. From May 1988 through August 2005, 71 patients with achalasia underwent transabdominal esophagocardiomyotomy and partial posterior fundoplication. Barium swallow, manometry, and 24-h pH studies were performed in all patients preoperatively. Manometry and 24-h pH monitoring were only carried out in 58 patients at the third post-operative week and in 43 patients during follow-up, even though 52 patients were included in the follow-up. There were no operative deaths or complications. All the 71 patients were able to eat semifluid or solid food without dysphagia and heartburn at discharge. Esophageal barium studies showed that the maximum esophageal diameter decreased 2.2 cm and the minimum gastroesophageal junction diameter increased 8.4 mm after operation. Manometry examination in 58 patients revealed that the lower esophageal sphincter resting pressure decreased 15.0 mmHg in the wake of the procedure. Twenty-four hour pH monitoring demonstrated that reflux events were within the normal post-operative range. Fifty-five of the 58 patients had normal DeMeester scores. Among the patients with a mean 90-month follow-up, 49 patients had normal intake of food without reflux, the remaining three had mild dysphagia without requiring treatment. All the patients resumed their preoperative work and social activities. The manometry and 24-h pH studies in the 43 patients showed there were no significant changes between the third post-operative week and during follow-up. Transabdominal esophagocardiomyotomy and posterior partial fundoplication are able to relieve the functional outflow obstruction of the lower esophageal sphincter, obviate the rehealing of the myotomy edge and prevent gastroesophageal reflux in patients who have undergone myotomy alone.


Subject(s)
Cardia/surgery , Esophageal Achalasia/surgery , Esophagus/surgery , Fundoplication , Adolescent , Adult , Aged , Deglutition Disorders/etiology , Deglutition Disorders/surgery , Esophageal Achalasia/complications , Esophageal pH Monitoring , Female , Follow-Up Studies , Gastroesophageal Reflux/etiology , Gastroesophageal Reflux/surgery , Heartburn/etiology , Heartburn/surgery , Humans , Male , Manometry , Middle Aged , Treatment Outcome
7.
Phys Rev B Condens Matter ; 53(5): 2627-2632, 1996 Feb 01.
Article in English | MEDLINE | ID: mdl-9983770
8.
11.
Phys Rev B Condens Matter ; 48(6): 3792-3802, 1993 Aug 01.
Article in English | MEDLINE | ID: mdl-10008827
12.
Phys Rev B Condens Matter ; 46(18): 11681-11687, 1992 Nov 01.
Article in English | MEDLINE | ID: mdl-10003057
SELECTION OF CITATIONS
SEARCH DETAIL
...